advertisement

---

Di Polo A 10

Showing records 1 to 10 | Display all abstracts from Di Polo A

94476 Perspectives for preclinical mouse models of glaucoma after Boston keratoprosthesis type 1
Geoffrion D
Experimental Eye Research 2021; 208: 108615

---

94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Belforte N
Molecular Neurodegeneration 2021; 16: 43

---

94476 Perspectives for preclinical mouse models of glaucoma after Boston keratoprosthesis type 1
Robert MC
Experimental Eye Research 2021; 208: 108615

---

94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Agostinone J
Molecular Neurodegeneration 2021; 16: 43

---

94476 Perspectives for preclinical mouse models of glaucoma after Boston keratoprosthesis type 1
Chodosh J
Experimental Eye Research 2021; 208: 108615

---

94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Alarcon-Martinez L
Molecular Neurodegeneration 2021; 16: 43

---

94476 Perspectives for preclinical mouse models of glaucoma after Boston keratoprosthesis type 1
Di Polo A
Experimental Eye Research 2021; 208: 108615

---

94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Villafranca-Baughman D; Dotigny F
Molecular Neurodegeneration 2021; 16: 43

---

94476 Perspectives for preclinical mouse models of glaucoma after Boston keratoprosthesis type 1
Harissi-Dagher M
Experimental Eye Research 2021; 208: 108615

---

94906 AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma
Cueva Vargas JL; Di Polo A
Molecular Neurodegeneration 2021; 16: 43

---